Sign in

Bunzl plc BNZL.L

Price 2,672p
as of 2026-09-04
55/100
No view
Quality61
Growth26
Balance-sheet strength57
Valuation62
Momentum61
Income62

Composite 55/100; the shares have moved about 21% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Growth ranks 26/100 — a moderate mark against it.

Case for

Income ranks 62/100 — a slight point in its favour. Valuation ranks 62/100 — a slight point in its favour. Momentum ranks 61/100 — a slight point in its favour.

Case against

Growth ranks 26/100 — a moderate mark against it.

What the company does Bunzl plc is a global distributor of non-food consumables, safety equipment, cleaning/hygiene supplies, and healthcare products, serving industrial, healthcare, retail, and foodservice sectors.

Key financials ROE 16.5%, ROA 5.2%, ROCE 28.4%; gross margin 28.9%, operating margin 7.1%, net margin 3.9%. Revenue growth 0.3%, EPS growth -4.9%. Debt/Equity 1.06, net debt/EBITDA 2.54, interest coverage 5.02.

Stock health Sideravia overall score 59.3 (average quality, fairly valued, positive momentum). Quality 61.4, momentum 80.4, income 79.7. Piotroski F-Score 7/9, Altman Z 4.59. Current ratio 1.39.

Price vs fair value The stock trades at a DISCOUNT of 55.20% versus our fair-value estimate and a PREMIUM of 6.50% versus the 12-month analyst target. - Discount vs fair value reflects high valuation percentiles (64.1/100) and forward P/E 15.27 (Valuation 64.1) - Premium vs target aligns with strong momentum scores (80.4) and 12m return 21.86% - Net margins 3.9% and EPS growth -4.9% weigh on fair-value gap - High income score (79.7) and dividend yield 2.7% support premium vs target

Looking forward Forward PEG 0.53 suggests undemanding growth valuation, while fwd P/E 15.27 and FCF yield 6.9% indicate reasonable pricing versus growth.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.